Taurocholic acid
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
| Taurocholic acid | |
|---|---|
| |
| Chemical name | 2-{[(3alpha,5beta, 7alpha,12alpha) -3,7,12-trihydroxy- 24-oxocholan-24-yl] amino} ethanesulfonic acid |
| Chemical formula | C26H45NO7S |
| Molecular mass | 515.7058 g/mol |
| CAS number | [81-24-3] |
| Density | x.xxx g/cm3 |
| Melting point | 125.0 °C |
| Boiling point | xx.x °C |
| SMILES | C[C@@]34[C@] (CC[C@@H]4[C@@H] (CCC(NCCS(O) (=O)=O)=O)C) ([H])[C@]2([H]) [C@H](O)C[C@]1 ([H])C[C@H](O)CC [C@@](C)1[C@] ([H])2C[C@@H]3O |
| Disclaimer and references | |
|
WikiDoc Resources for Taurocholic acid | |
|
Articles | |
|---|---|
|
Most recent articles on Taurocholic acid Most cited articles on Taurocholic acid | |
|
Media | |
|
Powerpoint slides on Taurocholic acid | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Taurocholic acid at Clinical Trials.gov Trial results on Taurocholic acid Clinical Trials on Taurocholic acid at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Taurocholic acid NICE Guidance on Taurocholic acid
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Taurocholic acid Discussion groups on Taurocholic acid Patient Handouts on Taurocholic acid Directions to Hospitals Treating Taurocholic acid Risk calculators and risk factors for Taurocholic acid
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Taurocholic acid | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Taurocholic acid, known also as cholaic acid, cholyltaurine, or acidum cholatauricum, is a deliquescent yellowish crystalline bile acid involved in the emulsification of fats. It occurs as a sodium salt in the bile of mammals. It is a conjugate of cholic acid with taurine. Medically it is used as a cholagogue and cholerectic.
Hydrolysis of taurocholic acid yields taurine, a nonessential amino acid.
Commercially, taurocholic acid is manufactured from cattle bile, a byproduct of the meat-processing industry.
See also
References
- Formula, model
- PubChem. Retrieved on February 5, 2006.
- http://www.chemexper.com/. Retrieved on February 5, 2006.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
